Charles River Laboratories International, Inc. · NYSE:CRL
LaPlume Joseph W received 5,257 Charles River Laboratories International, Inc. shares as an award (Form 4)
Traded May 29 to May 31, 2026 · Filed Jun 2, 2026
From May 29 to May 31, 2026, LaPlume Joseph W (EVP, Corp Strategy & Develop) received 5,257 Charles River Laboratories International, Inc. shares as an award at US$180.71 for US$950K, leaving 31,298 shares. Filed Jun 2, 2026 (Form 4).
- Awarded
- 5,257 shares
- Price
- US$180.71
- Value
- US$950K
- Holding after
- 31,298 shares
- Trading plan
- No
- Role
- EVP, Corp Strategy & Develop
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 29, 2026 | Common Stock | Award | 5,257 | US$180.71 | 32,277 | Direct |
| May 30, 2026 | Common Stock | Shares withheld for tax | 744 | US$180.71 | 31,533 | Direct |
| May 31, 2026 | Common Stock | Shares withheld for tax | 235 | US$180.71 | 31,298 | Direct |
Source
Related
- Charles River Laboratories International, Inc.
- LaPlume Joseph W
- Charles River Laboratories International, Inc. shareholders
- Form 4 · LaPlume Joseph W · Aug 11, 2026
- Form 4 · LaPlume Joseph W · May 28, 2026
- Form 4 · Parisotto Shannon M · Oct 7, 2026
- Form 4 · Coleman Glenn · Oct 2, 2026
- Schedule 13G/A · FMR LLC · Sep 8, 2026
- Form 4 · Foster James C · Aug 27, 2026
- Form 4 · Girshick Birgit · Aug 20, 2026